Related Experiment Videos

Prophylactic beta-blocker use to prevent perioperative morbidity and mortality

Alan C Finley1, Bruce M Elliott, Jacob J Robison

  • 1Vascular Surgery Section, MUSC, 96 Jonathan Lucas St., Suite 424, PO Box 250614, Charleston, SC 29425, USA.

Journal of the South Carolina Medical Association (1975)
|October 20, 2004
PubMed

Insights

Prophylactic beta-blockade is a safe and effective therapy for patients at risk of cardiac complications during surgery. A preoperative cardiac assessment is crucial to identify patients who will benefit from this strategy.

Area of Science:

  • Cardiology
  • Anesthesiology
  • Perioperative Medicine

Background:

  • Cardiovascular disease poses significant risks for perioperative morbidity and mortality.
  • Growing evidence supports the prophylactic use of beta-blockade to mitigate these risks.

Purpose of the Study:

  • To evaluate the efficacy and safety of prophylactic beta-blockade in patients undergoing surgery.
  • To emphasize the importance of preoperative cardiac assessment for patient selection.

Main Methods:

  • Review of existing literature on perioperative beta-blockade.
  • Analysis of patient outcomes related to cardiac complications and beta-blocker use.

Main Results:

  • Prophylactic beta-blockade demonstrates a growing evidence base for reducing perioperative cardiac complications.
  • Not all patients benefit, underscoring the need for individualized assessment.

Conclusions:

  • Prophylactic beta-blockade is a safe, efficacious, and cost-effective therapy for at-risk surgical patients.
  • Thorough preoperative cardiac assessment is essential for optimizing patient selection and outcomes.

Related Concept Videos

Adrenergic Antagonists: Pharmacological Actions of β-Receptor Blockers01:27

Adrenergic Antagonists: Pharmacological Actions of β-Receptor Blockers

β-receptor blockers significantly impact the cardiovascular system by counteracting catecholamine-induced sympathetic responses. These medications decrease heart rate, contractility, and cardiac output, potentially leading to cardiac depression, life-threatening bradycardia, and death. Therapeutically, β-blockers function as mild antihypertensives and are utilized in treating angina pectoris and cardiac arrhythmias. However, nonselective β-blockers inhibit β2-receptors in bronchial smooth...
Adrenergic Antagonists: ɑ and β-Receptor Blockers01:31

Adrenergic Antagonists: ɑ and β-Receptor Blockers

Third-generation β-blockers, such as labetalol and carvedilol, represent a significant advancement in managing cardiovascular conditions. Unlike conventional β-blockers, which can induce peripheral vasoconstriction, third-generation drugs block α1 adrenoceptors. This promotes vasodilation through several mechanisms, such as increased nitric oxide production, inhibition of calcium ion entry, opening of potassium ion channels, and antioxidant action. Labetalol, for instance, is clinically...
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
Heart Failure Drugs: β-Blockers01:22

Heart Failure Drugs: β-Blockers

β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation, vasodilation, and...
Antihypertensive Drugs: Types of β-Blockers01:28

Antihypertensive Drugs: Types of β-Blockers

β receptors are classified into three subclasses: β1, β2, and β3. β1 receptors are primarily located in the heart and kidneys. When they get activated, they increase heart rate, contractility, and renin release. This process enhances blood pressure and aids in stress management. In contrast, β2 receptors are situated mainly in the lungs, blood vessels, and skeletal muscles. Upon activation, they trigger smooth muscle relaxation, causing bronchodilation and vasodilation. This widens airways and...
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers01:24

Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers

Adrenergic stimulation generally impacts cardiac rate and rhythm. Specifically, stimulation of the β-adrenoceptors triggers an increase in intracellular calcium ion influx and pacemaker currents, which may cause arrhythmias. Catecholamines like adrenaline also demonstrate β2-adrenoceptor-mediated hypokalemia, impacting cardiac action potential and disrupting the normal cardiac rhythm. Class II antiarrhythmic drugs are β-adrenoceptor antagonists or β-blockers, which indirectly block calcium...